Congress appropriated nearly $6 billion for global HIV/AIDS work in fiscal year 2026. The money exists. But as of this week, programs in Mozambique have no remaining funds, 53 health facilities in Côte d'Ivoire face cuts, and dozens of implementing organizations are issuing layoff notices to clinical staff — because the U.S. State Department is deliberately not disbursing those funds. For the thousands of contractors, NGOs, and health system implementers who run the world's largest global health program, this is the most consequential procurement disruption of 2026.
What Happened on March 31, 2026
When the Trump administration took office in January 2025, it launched the America First Global Health Strategy — a sweeping restructuring of how the United States delivers health aid. The strategy called for replacing PEPFAR's decentralized network of NGO implementing partners with direct government-to-government contracts, shifting financial responsibility to recipient countries, and transitioning from USAID-administered programs to State Department control.
The administration gave itself six months — until March 31, 2026 — to have new bilateral health agreements in place and new contracting systems operational. That deadline passed without the systems being ready.
Implementing plans of this complexity typically require a year or more to develop. The State Department managed to complete 24 bilateral agreements with partner governments, falling well short of the 40 to 50 agreements it had targeted by March 31. Without those agreements in place, the new contracting architecture that was supposed to replace existing program vehicles simply does not exist — leaving the congressional appropriation sitting undisbursed while programs that depend on it run dry.
Bridge funding covering April through June 2026 has been announced, but multiple sources inside and outside the government confirm that disbursement timing remains deeply uncertain. The second bridge-funding installment, which was supposed to arrive in December 2025 and cover three months, often arrived weeks or months late. That pattern is repeating.
The Scale of What Is at Risk
PEPFAR — the President's Emergency Plan for AIDS Relief — is the largest global health program in history. Launched in 2003, it has saved an estimated 26 million lives and enabled 7.8 million babies to be born without HIV infection. It operates across more than 50 countries, primarily in sub-Saharan Africa.
In fiscal year 2025, bilateral PEPFAR programming received approximately $4.85 billion. The administration's FY 2026 budget request sought to reduce that to $2.9 billion — a 39% cut. Congress, however, appropriated funding at close to prior-year levels. The contradiction at the heart of the current crisis is that Congress has provided the money, but the executive branch is not releasing it.
The Centers for Disease Control and Prevention, which administered approximately 37% of PEPFAR bilateral assistance in recent years, is at the epicenter of the uncertainty. CDC-funded programs in sub-Saharan Africa — covering HIV testing, treatment monitoring, laboratory systems, and health workforce development — are operating without clear contractual authority and without reliable funding tranches arriving on schedule.
Key geographic flashpoints include:
- Mozambique: No remaining program funds as of early April
- Côte d'Ivoire: 53 health facilities facing service cuts, with support groups for HIV-positive teenagers discontinued
- Kenya: High Court suspended a bilateral health agreement with the U.S., ruling it may violate patient privacy and lacked adequate public consultation
- Zimbabwe and Zambia: Both countries rejected proposed bilateral deals over concerns about conditions linked to critical minerals access and health data sharing
- 12 African countries supervised by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) are at various stages of funding gaps
What This Means for Implementing Organizations and Contractors
The immediate procurement consequence is a freeze on the contracting ecosystem that delivers PEPFAR programs on the ground.
PEPFAR does not implement programs directly. It channels funding through a network of implementing partners — NGOs, academic institutions, and international organizations — that hold contracts or cooperative agreements with USAID (now the State Department) or CDC. Among the largest are Columbia University's ICAP, Harvard University, the Elizabeth Glaser Pediatric AIDS Foundation, and the AIDSRelief consortium led by Catholic Relief Services.
These organizations manage clinical service delivery, laboratory systems, supply chain logistics, health information management, and health workforce training across dozens of countries. When bridge funding is delayed or uncertain, the entire downstream supply chain stops functioning as normal:
- Hiring freezes prevent organizations from staffing new programs or backfilling vacancies
- Mandatory layoff notices are being issued to clinical staff — sometimes even when legal counsel advises this could expose organizations to litigation if funding ultimately arrives
- Multi-year vendor agreements for diagnostic equipment, consumables, and cold-chain logistics cannot be honored
- Subcontract payments to local implementing organizations in recipient countries are delayed or suspended, threatening local civil society capacity built over decades
- Training programs and capacity-building initiatives are put on hold, interrupting the upskilling pipeline that recipient governments depend on
One senior CDC official described the situation as a "controlled demolition" rather than an orderly transition — with the risk of program collapse materializing by June 2026 if funding does not flow reliably.
The workforce implications extend beyond current programs. Clinicians and public health specialists who have built careers in HIV programming are reporting that they are no longer confident there is a sustainable future in the field. Attrition of specialized staff — epidemiologists, laboratory scientists, supply chain managers with HIV-specific expertise — represents an institutional knowledge loss that cannot be quickly recovered if the program is eventually restored to scale.
Procurement Opportunities and Risks for the Development Sector
For contractors and implementing organizations watching this situation, several scenarios are now live:
The restructuring will create new contracting vehicles. The State Department's Bureau of Global Health Security and Diplomacy intends to establish direct bilateral contracts with recipient governments. When those contracting mechanisms eventually emerge, they will represent new opportunities — but with different structures than traditional PEPFAR sub-awards. Organizations able to work directly with host government health ministries, rather than through NGO intermediaries, will be best positioned.
Local and national organizations will be prioritized. The America First Global Health Strategy explicitly emphasizes transitioning programs toward country self-reliance by 2030. This means procurement will increasingly flow through national implementers — local NGOs, government agencies, and regional health organizations — rather than U.S.-based prime contractors. Organizations that have built relationships with national health ministries in Africa, Kenya, Nigeria, Uganda, and Mozambique are better positioned to capture this shift.
Commodities and frontline workers are protected (for now). The new strategy committed to maintaining 100% of funding levels for health commodities and frontline healthcare workers through FY 2026. This means procurement for antiretroviral drugs, HIV test kits, laboratory consumables, and medical supplies is more insulated than programmatic or technical assistance contracts. Companies in the health supplies and medical products space should differentiate between commodity procurement (relatively protected) and services/consulting (most at risk).
Multilateral health procurement is expanding to fill the gap. The Pandemic Fund, which launched its Fourth Call for Proposals in April 2026 targeting 15 high-risk countries, explicitly includes HIV-affected fragile states. UNICEF, WHO, and the Global Fund to Fight AIDS, Tuberculosis and Malaria are scaling their own procurement to compensate for the U.S. withdrawal in some geographies. Contractors that have historically relied on PEPFAR awards should actively develop relationships with these alternative funders. Browse active health consulting tenders and health supplies procurement across multilateral sources on BidsFactory.
The Global Fund remains the backstop. The U.S. contributes approximately one-third of the Global Fund's total pledges. In its most recent replenishment, the Global Fund secured $18.1 billion for the 2023–2025 cycle. Congress has continued to appropriate U.S. contributions to the Global Fund separately from bilateral PEPFAR funding — and those contributions are flowing. Organizations that can work through Global Fund country grants have a more stable procurement pipeline than those dependent on bilateral PEPFAR vehicles.
The Broader Pattern: U.S. Global Health Procurement in Transition
The PEPFAR crisis is not isolated. It is the sharpest expression of a broader restructuring of how the United States funds and contracts global health work.
USAID's effective dissolution in July 2025 eliminated the institutional infrastructure that had managed PEPFAR implementation for more than two decades. The contracting expertise, country knowledge, and implementing partner relationships that USAID accumulated over that period were partially transferred to the State Department but have not been fully reconstituted. A no Global AIDS Coordinator has been nominated, leaving a key policy and oversight role vacant.
The administration's FY 2026 budget request — if enacted — would reduce PEPFAR bilateral funding by $1.9 billion compared to the prior year. While Congress has resisted these cuts in appropriations, the executive branch retains discretion over disbursement timing and contracting structures. The legal and constitutional dimensions of that discretion are now being tested, with at least one congressional committee examining whether the withholding of appropriated funds violates the Impoundment Control Act.
For organizations active in global health procurement, the strategic implication is clear: dependency on a single bilateral funder is a structural vulnerability. Organizations that diversified their revenue base — across the Global Fund, multilateral development banks, bilateral donors outside the U.S. (UK FCDO notwithstanding its own cuts), and domestic health ministry contracts — are navigating this period with far greater resilience than those built around PEPFAR as a primary revenue stream.
What Contractors and Implementers Should Do Now
Register with multilateral alternatives. If your organization is not already registered as an implementing partner with UNICEF, WHO, UNDP, and the African Development Bank, begin that process now. Approval timelines can run three to six months, making registration a near-term priority rather than a medium-term one.
Map your commodity exposure separately from your services exposure. Commodity procurement — ARVs, diagnostics, cold-chain — is relatively protected under the current strategy. Services and technical assistance are at highest risk. Understanding which portion of your revenue comes from each category will shape your near-term strategy.
Engage host government health ministries directly. As bilateral agreements transition to government-to-government structures, access to public procurement in health ministries in Uganda, Nigeria, Tanzania, and other PEPFAR countries becomes commercially important. Browse Africa health tenders and track health procurement opportunities across BidsFactory's 140+ official sources.
Watch the June 2026 bridge-funding cliff. If bridge funding does not materialize by June, the risk of rapid program suspension increases significantly. Organizations should model a scenario where bridge funding is delayed by 60-90 days, and plan cash flow accordingly.
Looking Ahead
The IMF and World Bank Spring Meetings, scheduled for April 13–18 in Washington, D.C., will bring global health finance onto the agenda alongside macroeconomic discussions. Expect pressure on MDB health lending — particularly IDA and the African Development Bank — to scale up in response to the U.S. withdrawal.
For contractors and implementers, the immediate priority is clarity: clarity on which contracts survive the March 31 deadline, which bilateral agreements are in place, and what the June 2026 bridge-funding timeline actually looks like. The money that Congress appropriated exists. Whether and when it flows will determine whether the world's most successful global health program continues to function at scale.
Browse current health procurement opportunities across multilateral and bilateral sources on BidsFactory — and track award notices in Africa and Asia-Pacific where the restructuring is having the greatest impact.
